Lactobacillus gasseri BNR17 and No Significant Adverse Events

• Probiotic Lactobacillus sp. as a strategy for modulation of non-comorbid obesity: A systematic meta-analysis and GRADE assessment of randomized controlled trials.

  • 2025-04-23
  • Meta-Analysis · n = 58
  • Narra J 5(2)
  • • Juan Ajmn Lele
    • Karlos B Sihaloho
    • Dewa Vighneshwara
    • Derren Dch Rampengan
    • Chrisandi Y Rizqiansyah
    • Happy K Permatasari
    • Nelly Mayulu
    • Trina E Tallei
    • Nurpudji A Taslim
    • Bonglee Kim
    • Immanuelle Kezia
    • Fahrul Nurkolis
    • Rony A Syahputra

  • PubMed: 40951500
  • DOI: 10.52225/narra.v5i2.1562

  9 Insights on

  • No Significant Adverse Events

  • High evidence

  No significant adverse events were reported in either the intervention or control groups.

  Effect

  Neutral

  Effect size

  Small

  Significant

  No